BiomX (PHGE) Amortization - Intangibles (2020 - 2022)
BiomX (PHGE) posted Amortization - Intangibles of $380000.0 for Q4 2022, little changed sequentially from $380000.0 in Q3 2022, and little changed YoY from $380000.0 in Q4 2021.
BiomX (PHGE) Amortization - Intangibles (2020 - 2022) Analysis & Trends
BiomX has reported Amortization - Intangibles for 3 years, with the latest figure at $380000.0 in Q4 2022.
- Quarterly Amortization - Intangibles changed 0.0% year-over-year to $380000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $1.5 million (changed 0.0% YoY) and the FY2022 annual result came in at $1.5 million, changed 0.0% from the prior year.
- Amortization - Intangibles was little changed at $380000.0 in Q4 2022 per PHGE's latest filing, from $380000.0 in the prior quarter.
- Over five years, Amortization - Intangibles peaked at $380000.0 in Q2 2020 and troughed at $379000.0 in Q1 2020.
- A 3-year average of $379666.7 and a median of $380000.0 in 2020 frame the typical range for Amortization - Intangibles.
- The sharpest annual moves came in 2021 and 2022: Amortization - Intangibles grew 0.26% in 2021, then retreated 0.26% in 2022.
- Over 3 years, Amortization - Intangibles stood at $379000.0 in 2020, then increased by 0.26% to $380000.0 in 2021, then changed by 0.0% to $380000.0 in 2022.
- According to Business Quant data, Amortization - Intangibles over the past three periods registered $380000.0, $380000.0, and $379000.0 for Q4 2022, Q3 2022, and Q2 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BiomX | 351,774.34 | -816,225.66 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 380,000.00 |
| Sep 30, 2022 | 380,000.00 |
| Jun 30, 2022 | 379,000.00 |
| Mar 31, 2022 | 380,000.00 |
| Dec 31, 2021 | 380,000.00 |
| Sep 30, 2021 | 380,000.00 |
| Jun 30, 2021 | 380,000.00 |
| Mar 31, 2021 | 379,000.00 |
| Dec 31, 2020 | 379,000.00 |
| Sep 30, 2020 | 380,000.00 |
| Jun 30, 2020 | 380,000.00 |
| Mar 31, 2020 | 379,000.00 |